• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.75/15; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION 2.75/15; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 419115
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 01/21/2021
Event Type  Injury  
Manufacturer Narrative
Combination product: yes.
 
Event Description
An orsiro drug eluting stent system was selected for treatment in context of a (b)(6) study.The stent was implanted.The procedure is marked by the occurrence of an acute stent thrombosis with timi2 flow after post dilation, treated by 6f thromboaspiration to restore timi3 flow.
 
Manufacturer Narrative
Combination product: yes.After des placement in a tight cx stenosis an intraprocedural stent thrombosis was observed after post-dilatation, successfully treated with dilatation and thromboaspiration.No complication after the procedure were reported.The affected device was not returned and could therefore not be subjected to a technical investigation.However, the review of the provided angiographic images supported the reported sequence.The review of the product release documentation confirmed that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the provided documentation no device deficiency or manufacturing related root cause could be identified.The clinical event committee event adjudicated the case as periprocedural mi with intraprocedural st due to clinical reasons.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION 2.75/15
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key12196878
MDR Text Key262458909
Report Number1028232-2021-04067
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P170030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/20/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/04/2021
Device Model Number419115
Device Catalogue NumberSEE MODEL NO.
Device Lot Number11191475
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/01/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/05/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-